Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Staphylococcus Aureus Bacteremia Early Dual Therapy Improve Outcomes? (SABEDTIO) Clinical Trial

NCT07148960 is registered in ClinicalTrials.gov with West Virginia University as lead sponsor.

NCT NCT07148960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07148960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Staphylococcus Aureus Bacteremia Early Dual Therapy Improve Outcomes? (SABEDTIO) Clinical Trial
Lead sponsor
West Virginia University
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
September 15, 2025
Completion date
July 31, 2027
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

staphylococcus aureus bacteremia